Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • Bitcoin USD

    60,832.05
    -1,996.68 (-3.18%)
     
  • CMC Crypto 200

    1,261.13
    -96.87 (-7.13%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • Dow

    39,512.84
    +125.08 (+0.32%)
     
  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     
  • Gold

    2,366.90
    +26.60 (+1.14%)
     
  • Crude Oil

    78.20
    -1.06 (-1.34%)
     
  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Company News for May 26, 2020

  • Shares of Navidea Biopharmaceuticals, Inc. NAVB surged 91.3% after the biopharmaceutical company announced positive preliminary results from the second interim analysis of its ongoing NAV3-31 Phase 2B study.

  • Shares of Xeris Pharmaceuticals, Inc. XERS soared 28% after the specialty pharmaceutical company reported findings from outpatient portion of Phase 2 proof-of-concept study of its developmental ready-to-use glucagon in patients at risk of postprandial hypoglycemia following bariatric surgery.

  • Shares of T2 Biosystems, Inc. TTOO rose 12.8% after the in vitro diagnostics companysaid it expects to ship first SARS-CoV-2 tests to American customers as early as June-end.

  • Shares of Splunk Inc. SPLK gained 12.7% after the company reported first-quarter fiscal 2021 non-GAAP loss of 56 cents per share, which was lesser than the Zacks Consensus Estimate of a loss of 57 cents.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Splunk Inc. (SPLK) : Free Stock Analysis Report
 
Navidea Biopharmaceuticals, Inc. (NAVB) : Free Stock Analysis Report
 
T2 Biosystems, Inc. (TTOO) : Free Stock Analysis Report
 
Xeris Pharmaceuticals, Inc. (XERS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research